Hepatitis After Konȳne
Authors: HENRY S. KINGDON
Journal: Annals of Internal Medicine (1970)

Letters and Comments1 October 1970Hepatitis After KonȳneHENRY S. KINGDON, M.D., PH.D.HENRY S. KINGDON, M.D., PH.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-73-4-656_2 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: In recent years the use of factor VIII concentrates in hemophilia A has revolutionized the treatment of bleeding emergencies for these patients. Similar expectations are held for the use of concentrates of the prothrombin complex such as Konȳne® (concentrate of factors II, VII, IX, and X, produced by Cutter Laboratories, Berkeley, Calif.). The producers of all concentrates from pooled human plasma warn against the risk of hepatitis and warn that they cannot warrant that the product will be free of the hepatitis virus. The intent of this letter is to demonstrate that at least some batches of...Reference1. SCHROEDER D and MOZEN M: Australia antigen: distribution during Cohn ethanol fractionation of human plasma. Science 168:1462-1464, 1970 CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: HENRY S. KINGDON, M.D., PH.D.Affiliations: Department of Medicine Section of Hematology University of Chicago 950 East 59th St. Chicago, Ill. 60637 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byFractionated productsHepatitis C virus and transfusion transmitted liver disease: review.Prothrombin Complex Concentrates for Clinical UseThrombogenicity of factor IX concentrates and polyethylene glycol processingHepatitis risk in cardiac surgery patients receiving factor IX concentratesDisseminated Intravascular Coagulation and Blood Component TherapyIntravascular Coagulation with Use of Human Prothrombin Complex ConcentratesANDREW I. CEDERBAUM, M.D., PHILIP M. BLATT, M.D., HAROLD R. ROBERTS, M.D.The Prevalence of Hepatitis-B Antigen (HBsAg) and Its Antibody (ANTI-HBs) Among London Hemophiliacs and Blood Donors from London and Two Tropical AreasAcute coagulopathy following infusion of prothrombin complex concentrateHepatitis-B: A reviewCONCENTRATION OF HEPATITIS-B ANTIGEN FROM CLINICAL PREPARATIONS OF II, VII, IX, AND X BY POLYETHYLENE GLYCOL, TO ENHANCE DETECTION AND REMOVALBLOOD?ITS DERIVATIVES AND ITS PROBLEMS?FACTOR IXThrombogenic Materials in Prothrombin Complex ConcentratesPHILIP M. BLATT, M.D., ROGER L. LUNDBLAD, Ph.D., HENRY S. KINGDON, M.D., Ph.D., GEORGE McLEAN, M.D., HAROLD R. ROBERTS, M.D.Jaundice and Hepatitis B Antigen/Antibody in HemophiliaProthrombin Complex Concentrates in Acquired HypoprothrombinemiaS. G. SANDLER, M.D., F.A.C.P., C. E. RATH, M.D., F.A.C.P., A. RUDER, M.D.Post-Konyne Hepatitis: The Ineffectiveness of Screening for the Hepatitis B Antigen (HBAg)Hepatitis after konyne administrationne administrationAnaphylaxis after KonynePost-transfusion hepatitis: A review and prospectusHepatitis after Konyne Administration 1 October 1970Volume 73, Issue 4 Page: 656-657 Keywords Blood plasma Hemophilia A Hemorrhage Hepatitis A Hepatitis viruses Motivation ePublished: 1 December 2008 Issue Published: 1 October 1970 PDF downloadLoading ...